ALO17 Antibody Blocking peptide
ALO17 Antibody Blocking peptide
Product Specifications
Product Name Alternative
E3 ubiquitin-protein ligase RNF213, 632-, ALK lymphoma oligomerization partner on chromosome 17, Mysterin, RING finger protein 213, RNF213, ALO17, C17orf27, KIAA1554, KIAA1618, MYSTR
UniProt
Q63HN8
Field of Research
Metabolism Research
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the C-term region of human ALO17. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC052066-100 1x 100 µL
CD45 / LCA (B-Cell Marker) (rPTPRC/1460), CF405M conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882236-500 1x 500 µL
Cystatin A (CPTC-CSTA-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 